First Light Asset Management’s Pliant Therapeutics PLRX Stock Holding History

First Light Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,681,110	Closed	-$22.1M	–	42
2024 Q4	$22.1M	Sell	1,681,110 -894,436	-35%	-$12.2M	2.12%	17
2024 Q3	$28.9M	Sell	2,575,546 -825,667	-24%	-$10.3M	2.4%	21
2024 Q2	$36.6M	Sell	3,401,213 -133,780	-4%	-$1.72M	3.21%	14
2024 Q1	$52.7M	Sell	3,534,993 -56,783	-2%	-$937K	4.03%	5
2023 Q4	$65M	Buy	3,591,776 +658,516	+22%	+$10M	5.23%	5
2023 Q3	$50.9M	Buy	2,933,260 +1,123,084	+62%	+$19.5M	4.83%	5
2023 Q2	$32.8M	Buy	1,810,176 +384,822	+27%	+$9.11M	2.57%	12
2023 Q1	$37.9M	Buy	1,425,354 +367,473	+35%	+$10.5M	3.41%	10
2022 Q4	$20.4M	Buy	1,057,881 +92,767	+10%	+$1.94M	1.9%	21
2022 Q3	$20.2M	Buy	965,114 +195,744	+25%	+$3.75M	2.04%	21
2022 Q2	$6.16M	Buy	769,370 +358,042	+87%	+$2.29M	0.72%	36
2022 Q1	$2.88M	Buy	411,328 +24,432	+6%	+$249K	0.25%	46
2021 Q4	$5.22M	Buy	+386,896	New	+$6.15M	0.37%	47

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

First Light Asset Management's PLRX Position: Q1 2025 in Review

First Light Asset Management sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 1,681,110 shares — an estimated $22.1M sold.

First Light Asset Management first reported a position in PLRX in Q4 2021 and held it in 13 quarters. The position peaked at $65M in Q4 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

First Light Asset Management reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
First Light Asset Management sold 1,681,110 Pliant Therapeutics shares in Q1 2025, an estimated $22.1M.
First Light Asset Management first reported a position in Pliant Therapeutics in Q4 2021 and held it in 13 quarters.
First Light Asset Management's Pliant Therapeutics position peaked at $65M in Q4 2023.
140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on First Light Asset Management's 13F filing for Q1 2025, filed 15 May 2025.